|
特拉华州
|
| |
13-1840497
|
|
|
(国家或其他司法管辖区)
成立为法团或组织) |
| |
(I.R.S.雇主)
(识别号) |
|
|
格伦佩特中心东,3楼
弗兰克·伯尔大道300号,21号套房 新泽西蒂内克 (首席行政办公室地址) |
| |
07666-6712
(邮政编码) |
|
|
每一班的职称
|
| |
交易符号
|
| |
注册的每个交易所的名称
|
|
|
普通股,0.0001美元
每股票面价值 |
| |
PAHC
|
| |
纳斯达克股票市场
|
|
| 大型加速箱 | | | ☐ | | | 加速过滤器 | | | | |
| 非加速滤波器 | | | ☐ | | |
小型报告公司
|
| | ☐ | |
| 新兴成长型公司 | | | ☐ | | | | | | | |
| | |
页
|
| |||
第一部分-财务资料 | | | | | | | |
项1
财务报表(未经审计)
|
| | | | 3 | | |
综合业务报表
|
| | | | 3 | | |
综合收入报表
|
| | | | 4 | | |
综合资产负债表
|
| | | | 5 | | |
现金流动合并报表
|
| | | | 6 | | |
股东权益变动综合报表
|
| | | | 7 | | |
合并财务报表附注
|
| | | | 8 | | |
项2。
管理部门的财务状况及结果分析
操作
|
| | | | 22 | | |
项3。
市场风险的定量和定性披露
|
| | | | 32 | | |
项4。
控制和过程
|
| | | | 32 | | |
第二部分-其他资料 | | | | | | | |
项1
法律程序
|
| | | | 34 | | |
第1A项
危险因素
|
| | | | 34 | | |
项2。
未经登记的股本证券销售和收益的使用
|
| | | | 34 | | |
项3。
高级证券的违约
|
| | | | 34 | | |
项4。
矿山安全披露
|
| | | | 34 | | |
项5。
其他信息
|
| | | | 34 | | |
签名 | | | | | 36 | | |
| | |
三个月
|
| |||||||||
截至9月30日止的期间
|
| |
2019
|
| |
2018
|
| ||||||
| | |
(未经审计)
(单位:千,除外) 每股数额) |
| |||||||||
净销售额
|
| | | $ | 189,720 | | | | | $ | 200,153 | | |
出售货物的成本
|
| | | | 132,057 | | | | | | 134,348 | | |
毛利
|
| | | | 57,663 | | | | | | 65,805 | | |
销售、一般和行政费用
|
| | | | 47,516 | | | | | | 42,952 | | |
营业收入
|
| | | | 10,147 | | | | | | 22,853 | | |
利息费用,净额
|
| | | | 3,354 | | | | | | 2,783 | | |
外币(收益)损失净额
|
| | | | 3,221 | | | | | | (2,635) | | |
所得税前收入
|
| | | | 3,572 | | | | | | 22,705 | | |
所得税准备金
|
| | | | 1,057 | | | | | | 6,391 | | |
净收益
|
| | | $ | 2,515 | | | | | $ | 16,314 | | |
每股净收入 | | | | | | | | | | | | | |
基本
|
| | | $ | 0.06 | | | | | $ | 0.40 | | |
稀释
|
| | | $ | 0.06 | | | | | $ | 0.40 | | |
加权平均普通股 | | | | | | | | | | | | | |
基本
|
| | | | 40,454 | | | | | | 40,369 | | |
稀释
|
| | | | 40,504 | | | | | | 40,560 | | |
| | |
三个月
|
| |||||||||
截至9月30日止的期间
|
| |
2019
|
| |
2018
|
| ||||||
| | |
(未经审计)
(单位:千) |
| |||||||||
净收益
|
| | | $ | 2,515 | | | | | $ | 16,314 | | |
衍生工具公允价值的变化
|
| | | | (1,084) | | | | | | 541 | | |
外币换算调整
|
| | | | (6,823) | | | | | | (7,682) | | |
未确认的养恤金净收益(损失)
|
| | | | 120 | | | | | | 108 | | |
(准备金)所得税福利
|
| | | | 240 | | | | | | (162) | | |
其他综合收入(损失)
|
| | | | (7,547) | | | | | | (7,195) | | |
综合收入(损失)
|
| | | $ | (5,032) | | | | | $ | 9,119 | | |
|
| |
九月三十日
2019 |
| |
六月三十日
2019 |
| ||||||
| | |
(未经审计)
(单位:千,除份额外) 和每股数额) |
| |||||||||
资产 | | | | | | | | | | | | | |
现金和现金等价物
|
| | | $ | 54,893 | | | | | $ | 57,573 | | |
短期投资
|
| | | | 24,000 | | | | | | 24,000 | | |
应收账款净额
|
| | | | 145,444 | | | | | | 159,022 | | |
存货净额
|
| | | | 203,873 | | | | | | 198,322 | | |
其他流动资产
|
| | | | 27,302 | | | | | | 27,245 | | |
流动资产总额
|
| | | | 455,512 | | | | | | 466,162 | | |
不动产、厂房和设备,净额
|
| | | | 142,164 | | | | | | 140,235 | | |
无形资产,净额
|
| | | | 77,536 | | | | | | 47,478 | | |
善意
|
| | | | 52,990 | | | | | | 27,348 | | |
其他资产
|
| | | | 67,037 | | | | | | 45,448 | | |
总资产
|
| | | $ | 795,239 | | | | | $ | 726,671 | | |
负债和股东权益 | | | | | | | | | | | | | |
长期债务的当期部分
|
| | | $ | 14,084 | | | | | $ | 12,540 | | |
应付帐款
|
| | | | 61,372 | | | | | | 73,189 | | |
应计费用和其他流动负债
|
| | | | 66,517 | | | | | | 68,498 | | |
流动负债总额
|
| | | | 141,973 | | | | | | 154,227 | | |
循环信贷设施
|
| | | | 168,000 | | | | | | 96,000 | | |
长期债务
|
| | | | 213,040 | | | | | | 217,635 | | |
其他负债
|
| | | | 65,532 | | | | | | 42,794 | | |
负债总额
|
| | | | 588,545 | | | | | | 510,656 | | |
承付款和意外开支(附注9) | | | | | | | | | | | | | |
普通股,每股面值0.0001美元;300,000,000股普通股,20287,574股在2019年9月30日和6月30日发行和发行;30,000,000股B股授权发行,20,166,034股在2019和2018年9月30日和2018年6月30日发行和发行
|
| | | | 4 | | | | | | 4 | | |
优先股,每股面值0.0001美元;16,000,000股授权,不发行和发行股票
|
| | | | — | | | | | | — | | |
已付资本
|
| | | | 133,831 | | | | | | 133,266 | | |
留存收益
|
| | | | 166,587 | | | | | | 168,926 | | |
累计其他综合收入(损失)
|
| | | | (93,728) | | | | | | (86,181) | | |
股东权益总额
|
| | | | 206,694 | | | | | | 216,015 | | |
负债和股东权益共计
|
| | | $ | 795,239 | | | | | $ | 726,671 | | |
|
| | |
三个月
|
| |||||||||
截至9月30日止的期间
|
| |
2019
|
| |
2018
|
| ||||||
| | |
(未经审计)
(单位:千) |
| |||||||||
经营活动 | | | | | | | | | | | | | |
净收益
|
| | | $ | 2,515 | | | | | $ | 16,314 | | |
按业务活动调节净收入与提供(使用)现金净额的调整数:
|
| | | | | | | | | | | | |
折旧和摊销
|
| | | | 7,781 | | | | | | 6,691 | | |
发债成本摊销和债务贴现
|
| | | | 221 | | | | | | 221 | | |
股票补偿
|
| | | | 565 | | | | | | 565 | | |
与采购有关的货物销售成本
|
| | | | 280 | | | | | | — | | |
购置相关应计利息
|
| | | | 53 | | | | | | — | | |
递延所得税
|
| | | | (652) | | | | | | (473) | | |
外币(收益)损失净额
|
| | | | 1,660 | | | | | | (2,981) | | |
其他
|
| | | | 116 | | | | | | 266 | | |
经营资产和负债的变动,扣除业务收购后: | | | | | | | | | | | | | |
应收账款净额
|
| | | | 14,065 | | | | | | (85) | | |
存货净额
|
| | | | (9,086) | | | | | | (9,504) | | |
其他流动资产
|
| | | | (813) | | | | | | (3,654) | | |
其他资产
|
| | | | (1,071) | | | | | | 371 | | |
应付帐款
|
| | | | (11,834) | | | | | | 2,794 | | |
应计费用和其他负债
|
| | | | (7,370) | | | | | | (9,245) | | |
按业务活动提供(使用)的现金净额
|
| | | | (3,570) | | | | | | 1,280 | | |
投资活动 | | | | | | | | | | | | | |
资本支出
|
| | | | (7,675) | | | | | | (6,049) | | |
企业收购
|
| | | | (54,560) | | | | | | (9,838) | | |
其他,净额
|
| | | | (296) | | | | | | (262) | | |
投资活动提供(使用)现金净额
|
| | | | (62,531) | | | | | | (16,149) | | |
筹资活动 | | | | | | | | | | | | | |
循环信贷贷款
|
| | | | 119,000 | | | | | | 71,000 | | |
循环信贷贷款偿还额
|
| | | | (47,000) | | | | | | (56,000) | | |
偿还长期债务和其他
|
| | | | (3,215) | | | | | | (3,215) | | |
应付购置款票据的发行
|
| | | | — | | | | | | 3,775 | | |
发行的普通股收益
|
| | | | — | | | | | | 211 | | |
支付的股息
|
| | | | (4,854) | | | | | | (4,037) | | |
由筹资活动提供(使用)的现金净额
|
| | | | 63,931 | | | | | | 11,734 | | |
汇率变动对现金的影响
|
| | | | (510) | | | | | | (173) | | |
现金和现金等价物净增(减少)额
|
| | | | (2,680) | | | | | | (3,308) | | |
期初现金及现金等价物
|
| | | | 57,573 | | | | | | 29,168 | | |
期末现金及现金等价物
|
| | | $ | 54,893 | | | | | $ | 25,860 | | |
|
| | |
股份
普通股 |
| |
共同
股票 |
| |
首选
股票 |
| |
已付
资本 |
| |
留用
收益 |
| |
累积
其他 综合 收入(损失) |
| |
共计
|
| |||||||||||||||||||||
| | |
(未经审计)
(单位:千,份额除外) |
| |||||||||||||||||||||||||||||||||||||||
截至2019年6月30日
|
| | | | 40,453,608 | | | | | $ | 4 | | | | | $ | — | | | | | $ | 133,266 | | | | | $ | 168,926 | | | | | $ | (86,181) | | | | | $ | 216,015 | | |
综合收入(损失)
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 2,515 | | | | | | (7,547) | | | | | | (5,032) | | |
行使股票期权
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
宣布的股息(每股0.12美元)
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | (4,854) | | | | | | — | | | | | | (4,854) | | |
股票补偿费用
|
| | | | — | | | | | | — | | | | | | — | | | | | | 565 | | | | | | — | | | | | | — | | | | | | 565 | | |
截至2019年9月30日
|
| | | | 40,453,608 | | | | | $ | 4 | | | | | $ | — | | | | | $ | 133,831 | | | | | $ | 166,587 | | | | | $ | (93,728) | | | | | $ | 206,694 | | |
|
| | |
股份
普通股 |
| |
共同
股票 |
| |
首选
股票 |
| |
已付
资本 |
| |
留用
收益 |
| |
累积
其他 综合 收入(损失) |
| |
共计
|
| |||||||||||||||||||||
| | |
(未经审计)
(单位:千,份额除外) |
| |||||||||||||||||||||||||||||||||||||||
截至2018年6月30日
|
| | | | 40,357,708 | | | | | $ | 4 | | | | | $ | — | | | | | $ | 129,873 | | | | | $ | 131,560 | | | | | $ | (76,483) | | | | | $ | 184,954 | | |
采用新的收入标准
|
| | | | | | | | | | | | | | | | — | | | | | | — | | | | | | 1,245 | | | | | | — | | | | | | 1,245 | | |
综合收入(损失)
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 16,314 | | | | | | (7,195) | | | | | | 9,119 | | |
行使股票期权
|
| | | | 17,860 | | | | | | — | | | | | | — | | | | | | 211 | | | | | | — | | | | | | — | | | | | | 211 | | |
宣布的股息(每股0.10美元)
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | (4,037) | | | | | | — | | | | | | (4,037) | | |
股票补偿费用
|
| | | | — | | | | | | — | | | | | | — | | | | | | 565 | | | | | | — | | | | | | — | | | | | | 565 | | |
截至2018年9月30日
|
| | | | 40,375,568 | | | | | $ | 4 | | | | | $ | — | | | | | $ | 130,649 | | | | | $ | 145,082 | | | | | $ | (83,678) | | | | | $ | 192,057 | | |
| | |
三个月
|
| |||||||||
截至9月30日止的期间
|
| |
2019
|
| |
2018
|
| ||||||
净收益
|
| | | $ | 2,515 | | | | | $ | 16,314 | | |
加权平均股票数 - Basic
|
| | | | 40,454 | | | | | | 40,369 | | |
股票期权与限制性股票单位的稀释效应
|
| | | | 50 | | | | | | 191 | | |
加权平均股份数 - 稀释后
|
| | | | 40,504 | | | | | | 40,560 | | |
每股净收入 | | | | | | | | | | | | | |
基本
|
| | | $ | 0.06 | | | | | $ | 0.40 | | |
稀释
|
| | | $ | 0.06 | | | | | $ | 0.40 | | |
|
周转金,净额
|
| | | $ | 2,366 | | |
|
财产、厂房和设备
|
| | | | 2,005 | | |
|
定活无形资产
|
| | | | 32,100 | | |
| 善意 | | | | | 25,642 | | |
|
获得的净资产
|
| | | $ | 62,113 | | |
| | |
三个月
|
| |||||||||
截至9月30日止的期间
|
| |
2019
|
| |
2018
|
| ||||||
动物健康 | | | | | | | | | | | | | |
MFAS和其他
|
| | | $ | 75,034 | | | | | $ | 87,004 | | |
营养特产
|
| | | | 30,433 | | | | | | 26,970 | | |
疫苗
|
| | | | 16,383 | | | | | | 17,215 | | |
动物健康总额
|
| | | $ | 121,850 | | | | | $ | 131,189 | | |
矿物营养
|
| | | | 52,649 | | | | | | 54,838 | | |
性能产品
|
| | | | 15,221 | | | | | | 14,126 | | |
共计
|
| | | $ | 189,720 | | | | | $ | 200,153 | | |
| | |
三个月
|
| |||||||||
截至9月30日止的期间
|
| |
2019
|
| |
2018
|
| ||||||
美国
|
| | | $ | 118,487 | | | | | $ | 114,487 | | |
拉丁美洲和加拿大
|
| | | | 36,741 | | | | | | 38,883 | | |
欧洲、中东和非洲
|
| | | | 23,693 | | | | | | 24,836 | | |
亚太
|
| | | | 10,799 | | | | | | 21,947 | | |
共计
|
| | | $ | 189,720 | | | | | $ | 200,153 | | |
|
| | |
三个月
|
| |||||||||
截至9月30日止的期间
|
| |
2019
|
| |
2018
|
| ||||||
利息费用,净额 | | | | | | | | | | | | | |
定期贷款
|
| | | $ | 2,048 | | | | | $ | 2,112 | | |
循环信贷设施
|
| | | | 1,431 | | | | | | 747 | | |
发债成本摊销和债务贴现
|
| | | | 221 | | | | | | 221 | | |
购置相关应计利息
|
| | | | 53 | | | | | | — | | |
其他 | | | | | 80 | | | | | | 163 | | |
利息费用
|
| | | | 3,833 | | | | | | 3,243 | | |
利息(收入)
|
| | | | (479) | | | | | | (460) | | |
| | | | $ | 3,354 | | | | | $ | 2,783 | | |
|
| | |
三个月
|
| |||||||||
截至9月30日止的期间
|
| |
2019
|
| |
2018
|
| ||||||
折旧和摊销 | | | | | | | | | | | | | |
不动产、厂房和设备的折旧
|
| | | $ | 5,731 | | | | | $ | 5,188 | | |
无形资产摊销
|
| | | | 2,038 | | | | | | 1,491 | | |
其他资产摊销
|
| | | | 12 | | | | | | 12 | | |
| | | | $ | 7,781 | | | | | $ | 6,691 | | |
|
| |
九月三十日
2019 |
| |
六月三十日
2019 |
| ||||||
盘存 | | | | | | | | | | | | | |
原料
|
| | | $ | 71,737 | | | | | $ | 64,441 | | |
在制品 | | | | | 8,934 | | | | | | 10,699 | | |
成品
|
| | | | 123,202 | | | | | | 123,182 | | |
| | | | $ | 203,873 | | | | | $ | 198,322 | | |
|
|
| |
九月三十日
2019 |
| |
六月三十日
2019 |
| ||||||
商誉前滚 | | | | | | | | | | | | | |
期初余额
|
| | | $ | 27,348 | | | | | $ | 27,348 | | |
Osprey获取
|
| | | | 25,642 | | | | | | — | | |
期末余额
|
| | | $ | 52,990 | | | | | $ | 27,348 | | |
|
|
| |
九月三十日
2019 |
| |
六月三十日
2019 |
| ||||||
其他资产 | | | | | | | | | | | | | |
权益法投资
|
| | | $ | 4,374 | | | | | $ | 4,196 | | |
保险投资
|
| | | | 5,521 | | | | | | 5,431 | | |
递延融资费用
|
| | | | 1,404 | | | | | | 1,531 | | |
递延所得税
|
| | | | 17,357 | | | | | | 16,770 | | |
ROU经营租赁资产
|
| | | | 20,830 | | | | | | — | | |
存款 | | | | | 6,534 | | | | | | 7,024 | | |
补偿资产
|
| | | | 3,000 | | | | | | 3,000 | | |
其他 | | | | | 8,017 | | | | | | 7,496 | | |
| | | | $ | 67,037 | | | | | $ | 45,448 | | |
|
| |
九月三十日
2019 |
| |
六月三十日
2019 |
| ||||||
应计费用和其他流动负债 | | | | | | | | | | | | | |
与雇员有关
|
| | | $ | 25,999 | | | | | $ | 28,298 | | |
当期经营租赁负债
|
| | | | 6,267 | | | | | | — | | |
佣金和回扣
|
| | | | 7,366 | | | | | | 8,397 | | |
保险相关 | | | | | 1,274 | | | | | | 1,279 | | |
专业费用
|
| | | | 3,993 | | | | | | 5,212 | | |
所得税和其他税
|
| | | | 3,655 | | | | | | 6,067 | | |
重组成本
|
| | | | 2,655 | | | | | | 3,590 | | |
其他 | | | | | 15,308 | | | | | | 15,655 | | |
| | | | $ | 66,517 | | | | | $ | 68,498 | | |
|
2019年6月30日负债余额
|
| | | $ | 5,590 | | |
| 收费 | | | | | 425 | | |
| 付款 | | | | | (1,360) | | |
|
2019年9月30日负债余额
|
| | | $ | 4,655 | | |
|
| |
九月三十日
2019 |
| |
六月三十日
2019 |
| ||||||
其他负债 | | | | | | | | | | | | | |
美国养老金计划
|
| | | $ | 3,545 | | | | | $ | 3,934 | | |
国际退休计划
|
| | | | 5,139 | | | | | | 5,133 | | |
补充退休金、递延补偿及其他
|
| | | | 7,713 | | | | | | 7,605 | | |
长期和递延所得税
|
| | | | 9,022 | | | | | | 8,978 | | |
与购置有关的考虑
|
| | | | 7,603 | | | | | | — | | |
长期经营租赁负债
|
| | | | 15,546 | | | | | | — | | |
重组成本
|
| | | | 2,000 | | | | | | 2,000 | | |
其他长期负债
|
| | | | 14,964 | | | | | | 15,144 | | |
| | | | $ | 65,532 | | | | | $ | 42,794 | | |
|
|
| |
九月三十日
2019 |
| |
六月三十日
2019 |
| ||||||
累计其他综合收入(损失) | | | | | | | | | | | | | |
衍生仪器
|
| | | $ | (1,678) | | | | | $ | (594) | | |
外币换算调整
|
| | | | (78,048) | | | | | | (71,225) | | |
未确认的养恤金净收益(损失)
|
| | | | (19,930) | | | | | | (20,050) | | |
(规定)衍生工具所得税的福利
|
| | | | 418 | | | | | | 148 | | |
(规定)长期公司间投资的所得税福利
|
| | | | 8,166 | | | | | | 8,166 | | |
(准备金)养恤金收益所得税福利(损失)
|
| | | | (2,656) | | | | | | (2,626) | | |
| | | | $ | (93,728) | | | | | $ | (86,181) | | |
|
| |
九月三十日
2019 |
| |
六月三十日
2019 |
| ||||||
贷款期限2022年6月到期
|
| | | $ | 228,125 | | | | | $ | 231,250 | | |
其他 | | | | | 21 | | | | | | 40 | | |
| | | | | 228,146 | | | | | | 231,290 | | |
未摊销的债务发行成本和债务折扣
|
| | | | (1,022) | | | | | | (1,115) | | |
| | | | | 227,124 | | | | | | 230,175 | | |
减:当前到期日
|
| | | | (14,084) | | | | | | (12,540) | | |
| | | | $ | 213,040 | | | | | $ | 217,635 | | |
|
| |
九月三十日
2019 |
| |
资产负债表分类
|
| |||
资产: | | | | | | | | | | |
经营租赁ROU资产
|
| | | $ | 20,830 | | | | 其他资产 | |
负债: | | | | | | | | | | |
电流部分
|
| | | | 6,267 | | | |
应计费用和其他流动负债
|
|
非电流部分
|
| | | | 15,546 | | | | 其他负债 | |
经营租赁负债总额
|
| | | $ | 21,813 | | | | | |
| | |
三个月
|
| |||
截至9月30日止的期间
|
| |
2019
|
| |||
经营租赁费用
|
| | | $ | 1,851 | | |
可变租赁费用
|
| | | | 324 | | |
短期租赁费用
|
| | | | 203 | | |
租赁费用总额
|
| | | $ | 2,378 | | |
| | |
三个月
|
| |||
截至9月30日止的期间
|
| |
2019
|
| |||
用于ROU经营租赁的经营现金流
|
| | | $ | 1,677 | | |
为换取新的经营而获得的资产使用权
租赁负债(非现金) |
| | | $ | 3,790 | | |
| | |
截至
|
| |||
| | |
2019年9月30日
|
| |||
加权平均剩余租赁期(按年计) - ROU经营租赁
|
| | | | 6.36 | | |
加权平均折现率 - ROU经营租赁
|
| | | | 4.13% | | |
截至6月30日止的年份
|
| | | | | | |
2020 | | | | $ | 5,450 | | |
2021 | | | | | 5,856 | | |
2022 | | | | | 4,382 | | |
2023 | | | | | 2,258 | | |
2024 | | | | | 1,786 | | |
2025年及其后
|
| | | | 5,473 | | |
租赁付款总额
|
| | | | 25,205 | | |
减:利息
|
| | | | 3,392 | | |
经营租赁负债总额
|
| | | $ | 21,813 | | |
截至6月30日的年份
|
| | | | | | |
2020 | | | | $ | 5,815 | | |
2021 | | | | | 4,160 | | |
2022 | | | | | 3,191 | | |
2023 | | | | | 1,445 | | |
2024 | | | | | 865 | | |
此后 | | | | | 765 | | |
最低租赁付款总额
|
| | | $ | 16,241 | | |
仪器
|
| |
树篱
|
| |
概念
数额在 九月三十日 2019 |
| |
合并
资产负债表 |
| |
资产(负债)
公允价值 |
| |||||||||
|
九月三十日
2019 |
| |
六月三十日
2019 |
| |||||||||||||||||
备选方案 | | |
巴西皇家电话公司
|
| |
R$90,000
|
| |
(1)
|
| | | $ | 390 | | | | | $ | 413 | | |
备选方案 | | |
巴西里亚尔
|
| |
R$90,000
|
| |
(1)
|
| | | $ | (370) | | | | | $ | (30) | | |
互换 | | |
利率互换
|
| |
$150,000
|
| |
其他资产/
(其他负债) |
| | | $ | (1,698) | | | | | $ | (977) | | |
截至9月30日止的三个月
|
| ||||||||||||||||||||||||||||||||||||||||||
| | | | | |
在保监处记录的增益(损失)
|
| |
中确认的收益(损失)
综合业务报表 |
| |
合并报表
业务线 项目共计 |
| ||||||||||||||||||||||||||||||
仪器
|
| |
对冲
|
| |
2019
|
| |
2018
|
| |
合并
陈述 行动部 |
| |
2019
|
| |
2018
|
| |
2019
|
| |
2018
|
| ||||||||||||||||||
备选方案 | | |
巴西皇家电话公司
|
| | | $ | (363) | | | | | $ | (109) | | | | 出售货物的成本 | | | | $ | (45) | | | | | $ | 1084 | | | | | $ | 132,057 | | | | | $ | 134,348 | | |
互换 | | | 利率互换 | | | | $ | (721) | | | | | $ | 650 | | | |
利息费用,净额
|
| | | $ | — | | | | | $ | — | | | | | $ | 3,354 | | | | | $ | 2,783 | | |
|
| |
2019年9月30日
|
| |
2019年6月30日
|
| ||||||||||||||||||||||||||||||
| | |
一级
|
| |
二级
|
| |
三级
|
| |
一级
|
| |
二级
|
| |
三级
|
| ||||||||||||||||||
短期投资
|
| | | $ | 24,000 | | | | | $ | — | | | | | $ | — | | | | | $ | 24,000 | | | | | $ | — | | | | | $ | — | | |
衍生资产(负债)
|
| | | $ | — | | | | | $ | 20 | | | | | $ | — | | | | | $ | — | | | | | $ | 383 | | | | | $ | — | | |
利率互换(负债)
|
| | | $ | — | | | | | $ | (1,698) | | | | | $ | — | | | | | $ | — | | | | | $ | (977) | | | | | $ | — | | |
关于购置的或有考虑
|
| | | $ | — | | | | | $ | — | | | | | $ | (7,603) | | | | | $ | — | | | | | $ | — | | | | | $ | — | | |
| | |
三个月
|
| |||||||||
截至9月30日止的期间
|
| |
2019
|
| |
2018
|
| ||||||
净销售额 | | | | | | | | | | | | | |
动物健康
|
| | | $ | 121,850 | | | | | $ | 131,189 | | |
矿物营养
|
| | | | 52,649 | | | | | | 54,838 | | |
性能产品
|
| | | | 15,221 | | | | | | 14,126 | | |
总段
|
| | | $ | 189,720 | | | | | $ | 200,153 | | |
折旧和摊销 | | | | | | | | | | | | | |
动物健康
|
| | | $ | 6,384 | | | | | $ | 5,356 | | |
矿物营养
|
| | | | 613 | | | | | | 597 | | |
性能产品
|
| | | | 377 | | | | | | 273 | | |
总段
|
| | | $ | 7,374 | | | | | $ | 6,226 | | |
调整后的EBITDA | | | | | | | | | | | | | |
动物健康
|
| | | $ | 25,061 | | | | | $ | 35,716 | | |
矿物营养
|
| | | | 3,475 | | | | | | 2,563 | | |
性能产品
|
| | | | 852 | | | | | | 716 | | |
总段
|
| | | $ | 29,388 | | | | | $ | 38,995 | | |
|
| | |
三个月
|
| |||||||||
截至9月30日止的期间
|
| |
2019
|
| |
2018
|
| ||||||
所得税前收入与调整后的EBITDA的核对
|
| | | | | | | | | | | | |
所得税前收入
|
| | | $ | 3,572 | | | | | $ | 22,705 | | |
利息费用,净额
|
| | | | 3,354 | | | | | | 2,783 | | |
折旧和摊销-分段总额
|
| | | | 7,374 | | | | | | 6,226 | | |
折旧和摊销-公司
|
| | | | 407 | | | | | | 465 | | |
公司成本
|
| | | | 9,728 | | | | | | 8,886 | | |
重组成本
|
| | | | 425 | | | | | | — | | |
股票补偿
|
| | | | 565 | | | | | | 565 | | |
与采购有关的货物销售成本
|
| | | | 280 | | | | | | — | | |
与购置有关的交易费用
|
| | | | 462 | | | | | | — | | |
外币(收益)损失净额
|
| | | | 3,221 | | | | | | (2,635) | | |
调整后的EBITDA-总段数
|
| | | $ | 29,388 | | | | | $ | 38,995 | | |
|
|
| |
九月三十日
2019 |
| |
六月三十日
2019 |
| ||||||
可识别资产 | | | | | | | | | | | | | |
动物健康
|
| | | $ | 572,933 | | | | | $ | 508,864 | | |
矿物营养
|
| | | | 71,551 | | | | | | 67,662 | | |
性能产品
|
| | | | 33,323 | | | | | | 32,886 | | |
总段
|
| | | | 677,807 | | | | | | 609,412 | | |
企业
|
| | | | 117,432 | | | | | | 117,259 | | |
共计
|
| | | $ | 795,239 | | | | | $ | 726,671 | | |
| | |
三个月
|
| |||||||||||||||||||||
截至9月30日止的期间
|
| |
2019
|
| |
2018
|
| |
变化
|
| |||||||||||||||
| | |
(单位:千,但每股数额和百分比除外)
|
| |||||||||||||||||||||
净销售额
|
| | | $ | 189,720 | | | | | $ | 200,153 | | | | | $ | (10,433) | | | | |
|
(5)%
|
| |
毛利
|
| | | | 57,663 | | | | | | 65,805 | | | | | | (8,142) | | | | |
|
(12)%
|
| |
销售、一般和行政费用
|
| | | | 47,516 | | | | | | 42,952 | | | | | | 4,564 | | | | |
|
11%
|
| |
营业收入
|
| | | | 10,147 | | | | | | 22,853 | | | | | | (12,706) | | | | |
|
(56)%
|
| |
利息费用,净额
|
| | | | 3,354 | | | | | | 2,783 | | | | | | 571 | | | | |
|
21%
|
| |
外币(收益)损失净额
|
| | | | 3,221 | | | | | | (2,635) | | | | | | 5,856 | | | | |
|
*
|
| |
所得税前收入
|
| | | | 3,572 | | | | | | 22,705 | | | | | | (19,133) | | | | |
|
(84)%
|
| |
所得税准备金
|
| | | | 1,057 | | | | | | 6,391 | | | | | | (5,334) | | | | |
|
(83)%
|
| |
净收益
|
| | | $ | 2,515 | | | | | $ | 16,314 | | | | | $ | (13,799) | | | | |
|
(85)%
|
| |
每股净收入 | | | | | | | | | | | | | | | | | | | | | | | | | |
基本
|
| | | $ | 0.06 | | | | | $ | 0.40 | | | | | $ | (0.34) | | | | | | | | |
稀释
|
| | | $ | 0.06 | | | | | $ | 0.40 | | | | | $ | (0.34) | | | | | | | | |
加权平均流通股数 | | | | | | | | | | | | | | | | | | | | | | | | | |
基本
|
| | | | 40,454 | | | | | | 40,369 | | | | | | | | | | | | | | |
稀释
|
| | | | 40,504 | | | | | | 40,560 | | | | | | | | | | | | | | |
净销售额比率 | | | | | | | | | | | | | | | | | | | | | | | | | |
毛利
|
| | |
|
30.4%
|
| | | |
|
32.9%
|
| | | | | | | | | | | | | |
销售、一般和行政费用
|
| | |
|
25.0%
|
| | | |
|
21.5%
|
| | | | | | | | | | | | | |
营业收入
|
| | |
|
5.3%
|
| | | |
|
11.4%
|
| | | | | | | | | | | | | |
所得税前收入
|
| | |
|
1.9%
|
| | | |
|
11.3%
|
| | | | | | | | | | | | | |
净收益
|
| | |
|
1.3%
|
| | | |
|
8.2%
|
| | | | | | | | | | | | | |
有效税率
|
| | |
|
29.6%
|
| | | |
|
28.1%
|
| | | | | | | | | | | | | |
| | |
三个月
|
| |||||||||||||||||||||
截至9月30日止的期间
|
| |
2019
|
| |
2018
|
| |
变化
|
| |||||||||||||||
| | |
(千,百分比除外)
|
| |||||||||||||||||||||
净销售额 | | | | | |||||||||||||||||||||
MFAS和其他
|
| | | $ | 75,034 | | | | | $ | 87,004 | | | | | $ | (11,970) | | | | |
|
(14)%
|
| |
营养特产
|
| | | | 30,433 | | | | | | 26,970 | | | | | | 3,463 | | | | |
|
13%
|
| |
疫苗
|
| | | | 16,383 | | | | | | 17,215 | | | | | | (832) | | | | |
|
(5)%
|
| |
动物健康
|
| | | | 121,850 | | | | | | 131,189 | | | | | | (9,339) | | | | |
|
(7)%
|
| |
矿物营养
|
| | | | 52,649 | | | | | | 54,838 | | | | | | (2,189) | | | | |
|
(4)%
|
| |
性能产品
|
| | | | 15,221 | | | | | | 14,126 | | | | | | 1,095 | | | | |
|
8%
|
| |
共计
|
| | | $ | 189,720 | | | | | $ | 200,153 | | | | | $ | (10,433) | | | | |
|
(5)%
|
| |
调整后的EBITDA | | | | | | | | | | | | | | | | | | | | | | | | | |
动物健康
|
| | | $ | 25,061 | | | | | $ | 35,716 | | | | | $ | (10,655) | | | | |
|
(30)%
|
| |
矿物营养
|
| | | | 3,475 | | | | | | 2,563 | | | | | | 912 | | | | |
|
36%
|
| |
性能产品
|
| | | | 852 | | | | | | 716 | | | | | | 136 | | | | |
|
19%
|
| |
企业
|
| | | | (9,728) | | | | | | (8,886) | | | | | | (842) | | | | |
|
*
|
| |
共计
|
| | | $ | 19,660 | | | | | $ | 30,109 | | | | | $ | (10,449) | | | | |
|
(35)%
|
| |
调整后的EBITDA对净销售额的比率 | | | | | | | | | | | | | | | | | | | | | | | | | |
动物健康
|
| | |
|
20.6%
|
| | | |
|
27.2%
|
| | | | | | | | | | | | | |
矿物营养
|
| | |
|
6.6%
|
| | | |
|
4.7%
|
| | | | | | | | | | | | | |
性能产品
|
| | |
|
5.6%
|
| | | |
|
5.1%
|
| | | | | | | | | | | | | |
法人(1)
|
| | |
|
(5.1)%
|
| | | |
|
(4.4)%
|
| | | | | | | | | | | | | |
共计(1)
|
| | |
|
10.4%
|
| | | |
|
15.0%
|
| | | | | | | | | | | | | |
| | |
三个月
|
| |||||||||||||||||||||
截至9月30日止的期间
|
| |
2019
|
| |
2018
|
| |
变化
|
| |||||||||||||||
| | |
(千,百分比除外)
|
| |||||||||||||||||||||
净收益
|
| | | $ | 2,515 | | | | | $ | 16,314 | | | | | $ | (13,799) | | | | |
|
(85)%
|
| |
利息费用,净额
|
| | | | 3,354 | | | | | | 2,783 | | | | | | 571 | | | | |
|
21%
|
| |
所得税准备金
|
| | | | 1,057 | | | | | | 6,391 | | | | | | (5,334) | | | | |
|
(83)%
|
| |
折旧和摊销
|
| | | | 7,781 | | | | | | 6,691 | | | | | | 1,090 | | | | |
|
16%
|
| |
EBITDA | | | | | 14,707 | | | | | | 32,179 | | | | | | (17,472) | | | | |
|
(54)%
|
| |
重组成本
|
| | | | 425 | | | | | | — | | | | | | 425 | | | | |
|
*
|
| |
股票补偿
|
| | | | 565 | | | | | | 565 | | | | | | — | | | | |
|
0%
|
| |
与采购有关的货物销售成本
|
| | | | 280 | | | | | | — | | | | | | 280 | | | | |
|
*
|
| |
与购置有关的交易费用
|
| | | | 462 | | | | | | — | | | | | | 462 | | | | |
|
*
|
| |
外币(收益)损失净额
|
| | | | 3,221 | | | | | | (2,635) | | | | | | 5,856 | | | | |
|
*
|
| |
调整后的EBITDA
|
| | | $ | 19,660 | | | | | $ | 30,109 | | | | | $ | (10,449) | | | | |
|
(35)%
|
| |
| | |
三个月
|
| |||||||||||||||
截至9月30日止的期间
|
| |
2019
|
| |
2018
|
| |
改变
|
| |||||||||
| | |
(单位:千)
|
| |||||||||||||||
由/(使用)提供的现金: | | | | | |||||||||||||||
经营活动
|
| | | $ | (3,570) | | | | | $ | 1,280 | | | | | $ | (4,850) | | |
投资活动
|
| | | | (62,531) | | | | | | (16,149) | | | | | | (46,382) | | |
筹资活动
|
| | | | 63,931 | | | | | | 11,734 | | | | | | 52,197 | | |
汇率变动对现金的影响
和现金等价物 |
| | | | (510) | | | | | | (173) | | | | | | (337) | | |
现金和现金等价物净增(减)额
|
| | | $ | (2,680) | | | | | $ | (3,308) | | | | | $ | 628 | | |
| | |
三个月
|
| |||||||||||||||
截至9月30日止的期间
|
| |
2019
|
| |
2018
|
| |
改变
|
| |||||||||
| | |
(单位:千)
|
| |||||||||||||||
EBITDA
|
| | | $ | 14,707 | | | | | $ | 32,179 | | | | | $ | (17,472) | | |
调整 | | | | | | | | | | | | | | | | | | | |
重组成本
|
| | | | 425 | | | | | | — | | | | | | 425 | | |
股票补偿
|
| | | | 565 | | | | | | 565 | | | | | | — | | |
与采购有关的货物销售成本
|
| | | | 280 | | | | | | — | | | | | | 280 | | |
与购置有关的交易费用
|
| | | | 462 | | | | | | — | | | | | | 462 | | |
外币(收益)损失净额
|
| | | | 3,221 | | | | | | (2,635) | | | | | | 5,856 | | |
已付利息
|
| | | | (3,201) | | | | | | (2,732) | | | | | | (469) | | |
已缴所得税
|
| | | | (4,657) | | | | | | (5,817) | | | | | | 1,160 | | |
经营资产和负债及其他项目的变动
|
| | | | (14,910) | | | | | | (20,280) | | | | | | 4,908 | | |
用于购置相关交易费用的现金
|
| | | | (462) | | | | | | — | | | | | | (462) | | |
按业务活动提供(使用)的现金净额
|
| | | $ | (3,570) | | | | | $ | 1,280 | | | | | $ | (4,850) | | |
|
| |
九月三十日
2019 |
| |
六月三十日
2019 |
| ||||||
| | |
(以千计,比率除外)
|
| |||||||||
现金及现金等价物及短期投资
|
| | | $ | 78,893 | | | | | $ | 81,573 | | |
营运资本
|
| | | | 248,730 | | | | | | 242,902 | | |
流动资产与流动负债比率
|
| | | | 2.94:1 | | | | | | 2.71:1 | | |
| | | | 表2.1菲布罗动物健康公司及其之间的资产购买协议,如买方、Osprey生物技术公司、公司以及Lauren Danielson和Vincent Scuilla,作为截至2019年8月1日的销售方(提交不包括某些附表(或类似附件)),该协议是根据条例S-K第601(A)(5)项提交的,注册人同意应SEC的请求向SEC提供补充。 | |
| | | | 表31.1首席执行官-2002年萨班斯-奥克斯利法案第302条规定的认证 | |
| | | | 表31.2首席财务官--2002年萨班斯-奥克斯利法案认证-第302条 | |
| | | | 表32.1首席执行官-根据萨班斯-2002年“奥克斯利法”第906条颁发的证书 | |
| | | | 表32.2首席财务官-根据萨班斯-2002年“奥克斯利法”第906条认证 | |
| | | | 展示101.INS*XBRL实例文档 | |
| | | | 展示101.SCH*XBRL分类法扩展模式文档 | |
| | | | 展示101.CAL*XBRL分类法扩展计算链接库文档 | |
| | | | 展示101.DEF*XBRL分类法扩展定义链接库文档 | |
| | | | 展品101.lab*XBRL分类法扩展标签Linkbase文档 | |
| | | | 展示101.PRE*XBRL分类法扩展表示链接库文档 | |
| | | | 菲布罗动物健康公司 | | |||
| 2019年11月4日 | | | 通过: | | |
/S/Jack C.Bendheim
杰克·本海姆
主席、总裁和首席执行官 |
|
| 2019年11月4日 | | | 通过: | | |
s/Richard G.Johnson
理查德·约翰逊
首席财务官 |
|